TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q2 2014. The put-call ratio across all filers is 10.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $3,177,000 | -71.9% | 277,773 | -55.7% | 0.31% | -63.7% |
Q2 2015 | $11,316,000 | -7.8% | 626,579 | -1.7% | 0.86% | +0.1% |
Q1 2015 | $12,270,000 | -2.0% | 637,454 | -10.8% | 0.86% | +3.6% |
Q4 2014 | $12,517,000 | +2.1% | 714,885 | +6.5% | 0.83% | -2.1% |
Q3 2014 | $12,265,000 | +3.0% | 671,360 | +29.8% | 0.85% | +14.0% |
Q2 2014 | $11,912,000 | +29.9% | 517,245 | +36.7% | 0.74% | +35.6% |
Q1 2014 | $9,167,000 | +73.8% | 378,345 | +80.3% | 0.55% | +88.0% |
Q4 2013 | $5,274,000 | +39.2% | 209,790 | +20.5% | 0.29% | +22.8% |
Q3 2013 | $3,789,000 | – | 174,150 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
Centaur Capital | 77,500 | $887,000 | 1.33% |
Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
RK Capital | 565,472 | $6,469,000 | 1.18% |
Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |